BRCA1 and breast cancer: In term of prognosis, while the outcomes of metastatic BC in patients with germline BRCA1/2 mutations do not differ from non-carriers or untested subgroups in large real-life databases [50], the prognostic value of the somatic mutation of HRR genes has not been reported to date.